Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Affymetrix's Minimal Signal E. coli Array

Premium

Affymetrix this week launched a new multi-genome microarray for the detection and identification of pathogenic Escherichia coli during foodborne outbreaks.

According to Affymetrix, the Minimal Signature E. coli Array was designed by the US Food and Drug Administration's Center for Food Safety and Applied Nutrition, and can be run on on its semi-automated GeneAtlas Personal Microarray System as part of a 24-hour assay.

The chip content consists of biomarkers mined from over 250 E. coli whole genome sequences. In addition to containing more than 40,000 markers for every known E. coli gene, the array also includes 10,000 informative SNPs.

Affymetrix noted that its new chip can be used in combination with the FDA's Microbial ArrayTrack software, which supports microarray data storage, analysis, and visualization.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.